Folate-mediated targeting of polymers as components of colloidal drug delivery systems

Handbook of Drug Targeting and Monitoring: Developments, Challenges and Applications

Volumn , Issue , 2010, Pages 165-178

  Cavallaro, Gennara ^a   Licciardi, Mariano ^a   Pitarresi, Giovanna ^a   Giammona, Gaetano ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84979706352     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. Du, XL; Osborne, C; Goodwin, JS. Population-base assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J. Clinical Onc., 2002. 20(24),4636-4642.
2. Kaufmann, SHE. Paul Ehrlich: founder of chemotherapy. Nature Reviews Drug Discovery 7,2008,373, doi:10.1038/nrd2582.
3. Torchilin, VP. Drug Targeting. Eur. J. Pharm. Sci. 11 Suppl. (2000) 2, S81-S91.
4. Rihova, B, Receptor-mediated targeted drug or toxine delivery. Adv. Drug Deliv. Rev., 1998,29,273-289.
5. Cavallaro, G; Licciardi, M; Salmaso, S; Caliceti, P; Giammona, G. Folate mediated targeting of polymeric conjugates of gemcitabine. Int. J. Pharm., 2006,307,258-269.
6. Licciardi, M; Giammona, G; Du, J; Tang, Y; Lewis, AL; Armes, SP. New folate-functionalized biocompatible block copolymer micelles as potential anti-cancer drug delivery systems. Polymer, 2006,47,2946-2955.
7. Brannon-Peppas, L; Blanchette, JO, Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev., 2004,56(11),1649-1659.
8. Chatterjee, DK; Zhang, Y; Multi-functional nanoparticles for cancer therapy. Sci. and Technol. Adv. Mat., 2007,8,131-133.
9. Kwon, IC. Chitosan-based nanoparticles for cancer therapy; tumor specificity and enhanced therapeutic efficacy in tumor-bearing mice. J. Control. Release 2008 132(3), e69-e70.
10. Leong, KW; Mao, HQ; Truong-Le, VL; Roy, K; Walsh, SM; August, JT. DNA-polycation nanospheres as non viral gene delivery vehicles. J. Control. Release, 1998,53,183-193.
11. Lee, RJ; Low, PS. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem, 1994,269,3198-3204.
12. Gabizon, A; Goren, D; Horowitz, AT; Tzemach, D; Lossos, A; Siegal, T. Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. Adv. Drug Deliv. Rev., 1997,24(2-3),337-344.
13. Dass, C.R; Choong, PFM; Selective gene delivery for cancer therapy using cationic liposomes: In vivo proof of applicability. J. Control. Release (2006) 113(2),155-163.
14. Liu, Y; Lu, WL; Guo, J; Du, J; Li, T; Wu, JW; Wang, GL; Wang, JC; et. al; A potential target associated with both cancer and cancer stem cells: A combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. J. Control. Release, 2008,129(1),18-25.
15. Kataoka, K; Harada, A; Nagasaki, Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Deliv. Rev. (2001) 47,113-131.
16. Cavallaro, G; Licciardi, M; Giammona, G; Caliceti, P; Semenzato, A; Salmaso, S. Poly(hydroxyethylaspartamide) derivatives as colloidal drug carrier systems. J. Control. Release, 2003,89,285-295.
17. Cavallaro, G; Maniscalco, L; Licciardi, M; Giammona, G. Tamoxifen-loaded polymeric micelles: preparation, physico-chemical characterization and in vitro biological evaluation studies. Macromol. Biosc., 2004,4,1028-1038.
18. Licciardi, M; Tang, Y; Billingham, NC; Lewis, AL; Armes SP. Synthesis of novel folic acid-functionalized biocompatible block copolymers by atom transfer radical polymerization for gene delivery and encapsulation of hydrophobic drugs. Biomacromolecules, 2005,6,1085-1096.
19. Licciardi, M; Craparo, EF; Giammona, G; Armes, SP; Tang, Y; Lewis, AL. In vitro biological evaluation of folate-functionalized block copolymer micelles for selective anti-cancer drug delivery. Macromol. Biosci., 2008,8(7),615-626.
20. Mei, YF; Wadell, G. Replication competent Ad11 vectors possess a high potential for human cells targeted cancer therapy. Molecular Therapy, 2006,13, Supp. 1 S54.
21. Galanis, E; Vile, R; Russell, SJ. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors. Critical Reviews in Oncology/Hematology, 2001,38,177-192.
22. Ringsdorf, H. Structure and properties of pharmacologically active polymers. J. Polym. Sci., 1975,51,135-153.
23. Elnakat, H; Ratnam, M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv. Drug Deliv. Rev., 2004,56,1067-1084.
24. Antony, AC. Folate receptors: reflections on a personal odyssey and a perspective on unfolding truth. Adv. Drug Deliv. Rev., 2004,56,1059-1066.
25. Nakashima-Matsushita, N; Homma, T; Yu, S; Matsuda, T; Sunahara, N; Nakamura, T; Tsukano, M; Ratnam, M; Matsuyama, T. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum., 1999,42,1609-1616.
26. Antony, AC; The biological chemistry of folate receptors. Blood (1992) 79,2807-2820.
27. Leamon, CP; Low, PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc. Natl. Acad. Sci. USA, 1991,88,5572-5576.
28. Leamon, CP; Low, PS; Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. Biochem. J., 1993,291,855-860.
29. Shen, F; Ross, JF; Wang, X; Ratnam, M. Identification of a novel folate receptor, a truncated receptor, and receptor type beta in hematopoietic cells: cDNA cloning, expression, immunoreactivity, and tissue specificity. Biochemistry, 1994,33,1209-1215.
30. Garin-Chesa, P; Cmpbell, I; Saigo, P; Lewis, J; Old, L; Rettig, W. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol., 1993,142,557-567.
31. Ross, JF; Chaudhuri, PK; Ratnam, M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in estabilished cell lines - Physiologic and clinical implications. Cancer, 1994,73,2432-2443.
32. Toffoli, G; Cernigoi, C; Russo, A; Gallo, A; Bagnoli, M; Boiocchi, M. Overexpression of folate binding protein in ovarian cancer. Int. J. Cancer, 1997,74,193-198.
33. Wu, M; Gunning, W; Ratnam, M. Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus and cervix. Cancer Epidemiol. Biomarkers Prev, 1999,8,775-782.
34. Bueno, R; Appasani, K; Mercer, H; Lester, S; Sugarbaker, D. The alpha folate receptor is highly activated in malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg., 2001,121,225-233.
35. Gruner, BA; Weitman, SD. The folate receptor as a potential therapeutic anticancer target. Invest. New Drugs, 1998,16,205-219.
36. Leamon, CP; Low, PS. Folate-mediated targeting: from diagnostics to drug and gene delivery. Research Focus, 2001,6,44-50.
37. Lu, Y; Low, PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev., 2002,54,675-693.
38. Weitman, SD; Frazier, KM; Kamen, BA. The folate receptor in central nervous system malignancies of childhood. J. Neurooncol., 1994,21,107-112.
39. Li, PY; Del Vecchio, S; Fonti, R; Carriero, MV; Potena, MI; Botti, G; Miotti, S; Lastoria, S; Menare, S; Colnaghi, MI; Salvatore, M. Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. J. Nucl. Med, 1996,37(4),665-672.
40. Franklin, WA; Waintrub, M; Edwards, D; Christensen, K; Prendegrast, P; Woods, J; Bunn, PA; Kolhouse, JF. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int. J. Cancer Suppl., 1994,8,89-95.
41. Holm, J; Hansen, SI; Hoier-Madsen, M; Sondergaard, K; Bzorek, M. Folate receptor of human mammary adenocarcinoma. APMIS, 1994,102,413-419.
42. Reddy, JA; Low, PS. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit. Rev. Ther. Drug Carrier Syst., 1998,15,587-627.
43. Wang, S; Low, PS. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. J. Control. Release, 1998,53,39-48.
44. Sudimack, JBA; Lee, RJ. Targeted drug delivery via folate receptor. Adv. Drug Deliv. Rev., 2000,41,147-162.
45. Lu, Y; Low, PS. Immunotherapy of folate receptor-expressing tumours: review of recent advances and future prospects. Adv. Drug Deliv. Rev., 2003,91,17-29.
46. Leamon, C. P. Low, P. S. Cytotoxicity of momordin-folate conjugates in cultured human cells, J. Biol. Chem, 1992,267,24966-24971.
47. Leamon, CP; Pastan, I; Low, PS. Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain. J. Biol. Chem., 1993,268,24847-24854.
48. Atkinson, SF; Bettinger, T; Seymour, LW; Behr, JP; Ward, CM. Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells. J. Biol. Chem., 2001,276,27930-27935.
49. Lee, ES; Na, K; Bae, YH. Polymeric micelles for tumor pH and folate-mediated targeting,. J. Control. Release, 2003,91,103-113.
50. Liu, SQ; Wiradharma, N; Gao, SJ; Tong, YW; Yang, YY. Bio-functional micelles self- assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials, 2007,28,1423-1433.
51. Yang, X; Chen, Y; Yuan, R; Chen, G; Blanco, E; Gao, J; Shuai, X. Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells. Polymer, 2008,49,3477-3485.
52. Pan, X; Lee, R. Tumor-selective drug delivery via folate receptor-targeted liposomes. Expert. Opin. Drug Deliv, 2004,1(1),7-17.
53. Anderson, KE; Stevenson, BR; Rogers, JA. Folic acid-PEO-labeled liposomes to improve gastrointestinal absorption of encapsulated agents. J. Control. Release, 1999,60,189-198.
54. Gabizon, A; Shmeeda, H; Horowitz, AT; Zalipsky, S. Tumor cell targeting of liposome-entrapped drugs with phospholipids-anchored folic acid-PEG conjugates. Adv. Drug Deliv. Rev., 2004,56,1177-1192.
55. Shukla, S; Wu, G; Chatterjee, M; Yang, W; Sekido, M; Diop, LA; Müller, R; Sudimack, JJ; Lee, RJ; Barth, RF; Tjarks, W. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjugate Chem, 2003,14,158-167.
56. Agarwal, A; Saraf, S; Asthana, A; Gupta, U; Gajbhiye, V; Jain, NK. Ligand based dendritic systems for tumor targeting. Int. J. Pharm., 2008,350,3-13.
57. Li, S; Deshmukh, HM; Huang, L. Folate-mediated targeting of antisense oligodeoxynucleotides to ovarian cancer cells. Pharm. Res, 1998,15(10),1540-1545.
58. Zhao, XB; Lee, RJ. Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv. Drug Deliv. Rev., 2004,56,1193-1204.
59. Benns, JM; Mahato, RI; Kim, SW. Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. J. Control. Release, 2002,79,255-269.
60. Hattori, Y; Maitani, Y. Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer. J. Control. Release, 2004,97,173-183.
61. Pan, D; Turner, JL; Wooley, KL. Folic acid-conjugated nanostructured materials designed for cancer cell targeting. Chem. Comm., 2003,19,2400-2401.
62. Park, EK; Lee, SB; Lee, YM. Preparation and characterization of methoxy poly(ethylene glycol)/poly(s-caprolactone) amphiphilic block copolimeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials, 2005,26,1053-1061.
63. Yoshizawa, T; Hattori, Y; Hakoshima, M; Koga, K; Maitani, Y. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Eur. J. Pharm. Biopharm., 2008,70,718-725.
64. Wang, S; Lee, RJ; Mathias, CJ; Green, MA; Low, PS. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconjugate Chem, 1996,7,56-62.
65. Leamon, CP; DePrince, RB; Hendren, RW. Folate-mediated drug delivery: effect of alternative conjugation chemistry. J. Drug Target., 1999,7,157-169.
66. Lee, RJ; Low, PS. Folate as a targeting device for proteins utilizing folate receptor-mediated endocytosis, from: Methods in Molecular Medicine, vol. 25, Drug Targeting: Strategies, Principles, and Applications, edited by G.E. Francis and C. Delgado; Humana Press Inc., Totowa, NJ.
67. Gabizon, A; Horowitz, AT; Goren, D; Tzemach, D; Mandelbaum-Shavit, F; Qazen, MM; Zalipsky, S. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjugate Chem., 1999,10,289-298.
68. Blume, G; Cevc, G; Crommelin, MDJA; Bakker-Woudenberg, IAJM; Kluft, C; Storm, G. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta, 1993,1149,180-184.
69. Zalipsky, S; Puntambekar, B; Bolikas, P; Engbers, CM; Woodle, MC. Peptide attachment to extremities of liposomal surface grafted PEG Chains: Preparation of the long-circulating form of laminin pentapeptide, YIGSR. Bioconjugate Chem, 1995,6,705-708.
70. Zlipsky, S; Hansen, CB; Lopes de Menezes, DE; Allen, TM. Long-circulating polyethylene glycol-grafted immunoliposomes. J. Control. Release, 1996,39,153-161.
71. Yoo, HS; Park, TG. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J. Control. Release, 2004,100,247-256.
72. Yoo, HS; Park, TG. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Release, 2004,96,273-283.
73. Pan, XQ; Wang, H; Lee, RJ. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pharm. Res. (2003) 20(3),417-422.
74. Gabizon, A; Horowitz, AT; Goren, D; Tzemach, D; Shmeeda, H; Zalipsky, S. In vivo fate of folate-targeted poly-ethylene-glycol liposomes in tumor-bearing mice. Clin. Cancer Res. (2003) 9(17),6551-6559.